Archive Newsletter

41. 04.12.22 -- Cell Therapies For Solid Tumors: Considerations To Make Before Embarking 4/12/2022
    04/12/22 Cell & Gene Newsletter
42. 04.11.22 -- Partners Ready To Support Your Cell & Gene Clinical Trials 4/11/2022
    04/11/22 Cell & Gene Newsletter
43. 04.11.22 -- Integrated Solutions Enable Gene Therapy Commercialization 4/11/2022

    04/11/22 Cell & Gene Newsletter

44. 04.08.22 -- Find Cell And Gene Therapy Supply Chain Partners 4/8/2022
    04/08/22 Cell & Gene Newsletter
45. 04.08.22 -- Listen Now: CAR T-cells for Ovarian Cancer, Cell and Gene Solid Tumor Therapies, and more. 4/8/2022
    04/08/22 Cell & Gene Newsletter
46. 04.07.22 -- Cell & Gene Best Of March 4/7/2022
    04/07/22 Cell & Gene Newsletter
47. 04.06.22 -- How To Streamline And Support Clinical Trials 4/6/2022

    04/06/22 Cell & Gene Newsletter

48. 04.06.22 -- Emerging Bio Executives Tackle Regulatory, GMP And Talent Challenges 4/6/2022

    04/06/22 Cell & Gene Newsletter

49. 04.05.22 -- When You Need A Single-Use Solution -- Not Just A Bag 4/5/2022

    04/05/22 Cell & Gene Newsletter

50. 04.05.22 -- Targeting Solid Tumors With Cell Therapies 4/5/2022
    04/05/22 Cell & Gene Newsletter